C07K 14/43522
From scorpions
Official title: {from scorpions}
C07K14/43522 (From scorpions) appears on 110 US grants and 150 published applications in this corpus.
Search patents in C07K- Granted patents
- 110
- Published applications
- 150
- Assignees
- 84
- Inventors
- 307
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 4 |
| 2003 | 1 | 9 |
| 2004 | 4 | 3 |
| 2005 | 2 | 3 |
| 2006 | 2 | 8 |
| 2007 | 5 | 4 |
| 2008 | 4 | 2 |
| 2009 | 3 | 12 |
| 2010 | 6 | 1 |
| 2011 | 4 | 4 |
| 2012 | 3 | 0 |
| 2013 | 4 | 7 |
| 2014 | 3 | 7 |
| 2015 | 3 | 5 |
| 2016 | 4 | 6 |
| 2017 | 3 | 3 |
| 2018 | 2 | 4 |
| 2019 | 3 | 11 |
| 2020 | 7 | 12 |
| 2021 | 4 | 6 |
| 2022 | 4 | 7 |
| 2023 | 7 | 9 |
| 2024 | 8 | 11 |
| 2025 | 0 | 5 |
| 2026 | 1 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antimicrobial peptides with alpha-core helices31 Mar 2026US 12,590,131 B2Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Synthetic peptide SP2 and application thereof12 Nov 2024US 12,139,557 B2Taian City Qihang Biotechnology Co.
- HV1 modulators and uses10 Sep 2024US 12,084,481 B2The Regents of the University of California
- Conjugate vaccine targeting a disease-causing biological protein27 Aug 2024US 12,070,498 B2Funpep Co., Ltd.
- Methods of treating breast cancer30 Jul 2024US 12,048,732 B2Blaze Bioscience, Inc.
- Antimicrobial peptides with alpha-core helices24 Sep 2026US 2026/0285927 A1Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Hybrid antimicrobial peptides27 Aug 2026US 2026/0250337 A1The Trustees of the University of Pennsylvania
- Chimeric chlorotoxin receptors25 Jun 2026US 2026/0176311 A1The UAB Research Foundation
- Multivalent Chlorotoxin Chimeric Antigen Receptors19 Mar 2026US 2026/0078529 A1IN8bio, Inc.
- Recombinant expression vector for secretion of interleukin-21, and attenuated salmonella strain transformed by means of same12 Feb 2026US 2026/0041735 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
Most cited
By later US patents
- Directed evolution of novel binding proteins2,450US 5,223,409 AProtein Engineering Corporation · 1993
- Viruses expressing chimeric binding proteins1,136US 5,403,484 AProtein Engineering Corporation · 1995
- Directed evolution of novel binding proteins1,057US 5,571,698 AProtein Engineering Corporation · 1996
- Directed evolution of novel binding proteins286US 5,837,500 ADyax Corp. · 1998
- Engineered human-derived kunitz domains that inhibit human neutrophil elastase90US 5,663,143 ADyax Corp. · 1997